SPP1 and cancer: Interestingly, higher SPP1 expression consistently correlated with poor prognosis across multiple cancer types from The Cancer Genome Atlas (TCGA) project (Fig. 5b), as well as the two immunotherapy cohorts (Fig. 5c).